Home
→
Researchers
→

Mario Amendola

Researcher

Mario Amendola

Persistent identifiers

References for this unit in public registries: they allow cross-checking with other sources and do not change when the name does.

Affiliation

Fields of expertise

CRISPR-Cas9
HSPCs
Gene therapy
Nhej
CRISPR/Cas9
BCL11A
Thérapie génique
transgene

9 publications in HAL since 2022.

Data provenance

Sources : scanR, HAL. Data compiled on 27/10/2026. Found an error? It is corrected in the original source (HAL, RNSR, directory); see how.